시장보고서
상품코드
1429684

세계의 수의용 백신 시장 보고서(2024년)

Veterinary Vaccines Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

수의용 백신 시장 규모는 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 2028년에는 7.4%의 연평균 복합 성장률(CAGR)로 178억 5,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 경제 성장, 반려동물 보험의 보급 증가, 반려동물 소유율 증가, 정부의 노력 증가, 동물 건강에 대한 인식 증가 등의 요인에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 나노입자 개발에 대한 투자, 입자 기반 백신과 같은 서브 유닛 및 바이러스 생산 증가, 반려동물의 필수 및 정기 예방접종 일정을 지원하기 위한 파보바이러스, 디스템퍼, 아데노바이러스와 같은 질병에 대한 백신 생산이 포함될 것으로 예상됩니다. 기술 발전에 대한 투자 증가, 톡소이드 백신에 대한 관심 증가, mRNA 백신에 대한 투자 확대, 전략적 제휴 및 파트너십의 급증 등을 들 수 있습니다.

수의용 백신 시장은 다양한 질병으로 고통받는 동물의 수가 증가함에 따라 이러한 질병을 예방하고 치료하기 위한 백신에 대한 수요가 증가함에 따라 성장하고 있습니다. 동식물 보건국의 보고서에 따르면 영국에서 3,289건의 결핵이 새로 발견되어 소 결핵과 같은 질병이 동물에서 얼마나 중요한지 강조하고 있습니다. 소의 소 결핵과 같은 만성 질환을 포함한 질병의 확산으로 인해 예방 및 치료 솔루션을 제공하는 수의용 백신의 필요성이 증가하고 있습니다.

동물용 백신 시장의 성장은 동물성 식품에 대한 수요 증가로 인해 더욱 촉진되고 있습니다. 이 카테고리에는 쇠고기, 돼지육류, 가금육, 생선, 우유, 치즈, 버터, 계란 및 기타 동물성 식품 등 다양한 품목이 포함됩니다. 규제 준수와 식품 안전의 필수 사항으로 인해 동물의 질병을 예방하기 위해 수의용 백신의 채택이 증가하고 있습니다. 이러한 백신은 동물의 건강을 보호할 뿐만 아니라 질병 발생을 예방하고 소비자에게 식품의 품질과 안전성을 보장합니다. 세계 육류 공급량은 2030년까지 3억 7,400만 톤에 달할 것으로 예상되며, 세계 육류 단백질 소비량은 2020년 대비 14% 증가할 것으로 예상되어 동물성 식품에 대한 수요를 뒷받침하는 데 있어 수의용 백신의 중요한 역할이 강조되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 수의용 백신 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 가축용 백신
  • 반려동물용 백신
  • 세계의 수의용 백신 시장, 백신 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 약독화 생백신
  • 불활화 백신
  • 톡소이드 백신
  • 재조합 백신
  • 기타 백신 유형
  • 세계의 수의용 백신 시장, 질환별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 아나플라즈마증
  • 개파보바이러스
  • 구제역
  • 뉴캐슬병
  • 디스템퍼병
  • 인플루엔자
  • 돼지생식기호흡기증후군(PRRS)

제7장 지역 및 국가 분석

  • 세계의 수의용 백신 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 수의용 백신 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 수의용 백신 시장 경쟁 상황
  • 수의용 백신 시장 기업 개요
    • Zoetis Inc.
    • Boehringer Ingelheim GmbH
    • Merck &Co. Inc.
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale.

제31장 기타 주요 및 혁신적인 기업

  • Virbac Group
  • HIPRA
  • Biogenesis Bago
  • Kyoritsu Seiyaku Corporation
  • Phibro Animal Health Corporation
  • Century Vaccines Limited
  • BASF India Ltd.
  • Bayer Animal Health Cadila Vaccines Ltd.
  • Cargill India Pvt. Ltd.
  • China Animal Healthcare Ltd.
  • Merck/MSD Animal Health
  • Jurox Pty Ltd
  • Nimrod Veterinary Products Ltd.
  • Bimeda
  • Animalcare

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

A veterinary vaccine is a biological preparation designed to stimulate the immune response of an animal, aiming to reduce animal suffering, prevent the transmission of microorganisms within the animal population, and enhance the immune strength of animals for improved health. Additionally, veterinary vaccines play a crucial role in preventing the transmission of diseases from animals to humans.

Various types of veterinary vaccines include live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine variants. Inactivated vaccines, distinct from live attenuated vaccines, consist of dead or inactivated viruses and bacteria. The diseases targeted by these vaccines encompass anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome. The application areas for veterinary vaccines extend to both livestock vaccines and companion animal vaccines.

The veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides veterinary vaccines statistics, including veterinary vaccines industry global market size, regional shares, competitors with veterinary vaccines share, detailed veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. The veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary vaccines market size has grown strongly in recent years. It will grow from $12.47 billion in 2023 to $13.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in the historical period can be attributed to factors such as the growth of emerging markets, heightened pet spending, increased disease prevalence, a rise in poultry disease outbreaks, and an increased incidence of zoonotic diseases.

The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $17.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be attributed to factors such as economic growth, the increasing penetration of pet insurance, a rise in pet ownership, an increase in government initiatives, and growing awareness about animal health. Major trends in the forecast period include investments in the development of nanoparticles, increased production of subunit and virus-such as particle-based vaccines, manufacturing vaccines for diseases such as parvovirus, distemper, and adenovirus to support the mandatory and regular vaccination schedules for pet owners, heightened investment in technological advancements, increased focus on toxoid vaccines, a greater emphasis on investment in mRNA vaccines, and a surge in strategic collaborations and partnerships.

The veterinary vaccines market is experiencing growth driven by the increasing number of animals afflicted with various diseases, creating a demand for vaccines to prevent and treat these conditions. A report from the Animal and Plant Health Agency highlights 3289 new TB herd incidents detected in England, underscoring the significance of diseases such as bovine tuberculosis in animals. The prevalence of diseases, including chronic ailments such as bovine tuberculosis in cattle, contributes to the heightened need for veterinary vaccines, offering preventive and therapeutic solutions.

The growth of the veterinary vaccine market is further propelled by the rising demand for animal-derived food products. This category encompasses a variety of items, such as beef, pork, chicken, fish, milk, cheese, butter, eggs, and other ingredients sourced from animals. The prevention of diseases in animals, driven by regulatory compliance and the imperative for food safety, leads to an increased adoption of veterinary vaccines. These vaccines not only protect animal health but also ensure the prevention of disease outbreaks, assuring consumers of the quality and safety of food products. The global meat supply is projected to reach 374 Mt by 2030, with a predicted 14% increase in meat protein consumption globally compared to 2020, emphasizing the crucial role of veterinary vaccines in supporting the demand for animal-derived food products.

In the veterinary vaccines market, companies are actively forming strategic partnerships and collaborations to expand into new geographical regions and engage in joint research and development projects. Merck Animal Health, for example, established a four-year strategic alliance with Iowa State University, focusing on innovative solutions in animal health through collaborative efforts in research and development, manufacturing, technology exploration, and business expansion. Such partnerships aim to address animal health challenges globally. MSD Animal Health also entered a strategic partnership with Vinovo, enhancing the vaccination process and improving bird welfare by combining MSD Animal Health's vaccine product line with Vinovo's vaccine delivery system. Additionally, Wageningen bio veterinary research collaborated with Ceva to enhance research on emerging and reemerging diseases for animals.

Key players in the veterinary vaccine market are investing in innovation to maintain a competitive edge. Merck Animal Health, for instance, introduced a new three-in-one swine vaccine named Circumvent CML in June 2023. This vaccine offers protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. Circumvent CML combines multiple antigens and adjuvant systems in a single bottle, simplifying the vaccination process and reducing stress for animals and caretakers.

The regulatory landscape of the veterinary vaccines market is governed by authorities such as the European Medicines Agency and the US Center for Veterinary Biologics. In Europe, veterinary vaccine companies must adhere to specific technical requirements outlined in Directive 2001/82/EC and European Pharmacopoeia (Ph. Eur.). Safety tests are mandatory for approval, involving in vitro titration for activated vaccines and serological tests for inactivated vaccines. Batch standards for inactivated vaccines necessitate a dose double the standard for each batch, while activated vaccines must undergo testing with a batch ten times the standard dose. These regulatory measures ensure the safety and efficacy of veterinary vaccines.

Major companies operating in the veterinary vaccines market report are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Sante Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, BASF India Ltd., Bayer Animal Health Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Merck/MSD Animal Health, Jurox Pty Ltd., Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, Zoetis, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Sanofi Animal Health Inc., Novartis Animal Health, DBK Pharma S.A.E.

North America was the largest region in the veterinary vaccines market in 2023. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Application: Livestock Vaccines; Companion Animal Vaccines
  • 2) By Vaccine Type: Live Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Recombinant Vaccines; Other Vaccine Types
  • 3) By Disease Type: Anaplasmosis; Canine Parvovirus; Foot And Mouth Disease; Newcastle Disease; Distemper Disease; Influenza; Porcine Reproductive And Respiratory Syndrome (PRRS)
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Elanco Animal Health Incorporated; Ceva Sante Animale.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Vaccines Market Characteristics

3. Veterinary Vaccines Market Trends And Strategies

4. Veterinary Vaccines Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Veterinary Vaccines Market Size and Growth

  • 5.1. Global Veterinary Vaccines Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Veterinary Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Veterinary Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Vaccines Market Segmentation

  • 6.1. Global Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Livestock Vaccines
  • Companion Animal Vaccines
  • 6.2. Global Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Other Vaccine Types
  • 6.3. Global Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anaplasmosis
  • Canine Parvovirus
  • Foot And Mouth Disease
  • Newcastle Disease
  • Distemper Disease
  • Influenza
  • Porcine Reproductive And Respiratory Syndrome (PRRS)

7. Veterinary Vaccines Market Regional And Country Analysis

  • 7.1. Global Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Vaccines Market

  • 8.1. Asia-Pacific Veterinary Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Vaccines Market

  • 9.1. China Veterinary Vaccines Market Overview
  • 9.2. China Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Vaccines Market

  • 10.1. India Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Vaccines Market

  • 11.1. Japan Veterinary Vaccines Market Overview
  • 11.2. Japan Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Vaccines Market

  • 12.1. Australia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Vaccines Market

  • 13.1. Indonesia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Vaccines Market

  • 14.1. South Korea Veterinary Vaccines Market Overview
  • 14.2. South Korea Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Vaccines Market

  • 15.1. Western Europe Veterinary Vaccines Market Overview
  • 15.2. Western Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Vaccines Market

  • 16.1. UK Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Vaccines Market

  • 17.1. Germany Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Vaccines Market

  • 18.1. France Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Vaccines Market

  • 19.1. Italy Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Vaccines Market

  • 20.1. Spain Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Vaccines Market

  • 21.1. Eastern Europe Veterinary Vaccines Market Overview
  • 21.2. Eastern Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Vaccines Market

  • 22.1. Russia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Vaccines Market

  • 23.1. North America Veterinary Vaccines Market Overview
  • 23.2. North America Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Vaccines Market

  • 24.1. USA Veterinary Vaccines Market Overview
  • 24.2. USA Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Vaccines Market

  • 25.1. Canada Veterinary Vaccines Market Overview
  • 25.2. Canada Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Vaccines Market

  • 26.1. South America Veterinary Vaccines Market Overview
  • 26.2. South America Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Vaccines Market

  • 27.1. Brazil Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Vaccines Market

  • 28.1. Middle East Veterinary Vaccines Market Overview
  • 28.2. Middle East Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Vaccines Market

  • 29.1. Africa Veterinary Vaccines Market Overview
  • 29.2. Africa Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Vaccines Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Vaccines Market Competitive Landscape
  • 30.2. Veterinary Vaccines Market Company Profiles
    • 30.2.1. Zoetis Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Boehringer Ingelheim GmbH
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Elanco Animal Health Incorporated
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Ceva Sante Animale.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Veterinary Vaccines Market Other Major And Innovative Companies

  • 31.1. Virbac Group
  • 31.2. HIPRA
  • 31.3. Biogenesis Bago
  • 31.4. Kyoritsu Seiyaku Corporation
  • 31.5. Phibro Animal Health Corporation
  • 31.6. Century Vaccines Limited
  • 31.7. BASF India Ltd.
  • 31.8. Bayer Animal Health Cadila Vaccines Ltd.
  • 31.9. Cargill India Pvt. Ltd.
  • 31.10. China Animal Healthcare Ltd.
  • 31.11. Merck/MSD Animal Health
  • 31.12. Jurox Pty Ltd
  • 31.13. Nimrod Veterinary Products Ltd.
  • 31.14. Bimeda
  • 31.15. Animalcare

32. Global Veterinary Vaccines Market Competitive Benchmarking

33. Global Veterinary Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Vaccines Market

35. Veterinary Vaccines Market Future Outlook and Potential Analysis

  • 35.1 Veterinary Vaccines Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Vaccines Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Vaccines Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제